Sykesville, MD, United States of America

James Eugene Galen

This inventor holds 23 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Vaccine Development. Top assignees: University System of Maryland, National Research Council of Canada. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Eugene Galen. Retrieved from https://idiyas.com/inventor/james-eugene-galen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 3)

% Patents Active = 78.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 1)

Average Co-Inventor Count = 1.6

ph-index = 5

Forward Citations = 111(Granted Patents)

Location History:

Owings Mills, MD (US) (2002 - 2008)
Sykesville, MD (US) (2011 - 2018)
Eldersburg, MD (US) (2015 - 2023)

Company Filing History:

23 out of 2,027

University System of Maryland

patents

2 out of 1,039

National Research Council of Canada

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Live Attenuated Vaccines

Yeast-Based Immunotherapy

Heterologous Antigens

Bacterial Live Vectors

ClyA Hemolysin

Plasmid Maintenance

Microcin H47

Immune Response Elicitation

Excretion of Proteins

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12674131 - Live Attenuated Non-Transmissible Vaccines (2026-07-07),

2. 12440547 - Livetyphi vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof (2025-10-14),

3. 12384833 - Yeast-based immunotherapy againstinfection (2025-08-12),

4. 11744884 - Livevectors engineered to express heterologous outer membrane protein antigens and methods of use thereof (2023-09-05),

5. 11466075 - Yeast-based immunotherapy against clostridium difficile infection (2022-10-11),

6. 10046040 - [object Object] (2018-08-14),

7. 10010596 - Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens (2018-07-03),

8. 9446113 - Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens (2016-09-20),

9. 9051574 - Non-hemolytic ClyA for excretion of proteins (2015-06-09),

10. 9050283 - [object Object] (2015-06-09),

11. 9011871 - [object Object] (2015-04-21),

12. 8728760 - Microcin H47 plasmid selection system (2014-05-20),

13. 8137930 - [object Object] (2012-03-20),

14. 8076130 - Plasmid maintenance system for antigen delivery (2011-12-13),

15. 7459161 - Methods for eliciting an immune response using cytolysin and hemolysin fusion proteins (2008-12-02),

Title: The Inventor Profile of James Eugene Galen

Introduction: James Eugene Galen is a renowned inventor based in Sykesville, Maryland, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: James Eugene Galen holds several patents in diverse areas, showcasing his versatility and creativity in inventing new solutions to existing problems.

Career Highlights: Throughout his illustrious career, James Eugene Galen has consistently pushed the boundaries of innovation, earning recognition for his forward-thinking approach and problem-solving abilities.

Collaborations: James Eugene Galen has collaborated with leading experts in the industry, fostering a culture of innovation and knowledge-sharing to drive progress and development in his inventions.

Conclusion: James Eugene Galen's passion for innovation and his dedication to creating impactful solutions have solidified his reputation as a pioneering inventor in Sykesville, Maryland, and beyond.

Profile summary based on public USPTO records.